This is the supplier profile page of Pharmbio Korea Co.,Ltd., where buyers can explore products, connect directly with the supplier for pricing inquiries.
0
2F, Chungang University Dongmun-hall
Add Favorite
Report Supplier
Business Description
Since the Korea's first urolithiasis treatment "UROCITRA" in 1999, we have made every effort to be a leading maker in the field of urologic medicines. As a result, we have marketed "UROCITRA" and another urolithiasis treatment "ROWATINEX" successfully. Moreover, we have developed and supplied "ROWACHOL" for cholelithiasis treatments and "HEPADIAL" for dyspepsia symptom of the patients with hepato-biliary diseases. For more information about our products, please feel free to contact us at any time. Thank you
Export Capabilities
Declared by supplierPharmbio Korea Co.,Ltd. has been exporting since 2003.
Export start year
2003
Trade Capabilities
Business Terms
Trade Ability
